Visual outcome, ocular findings, and visual quality of life in patients with Fabry disease

References

• Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. Jama. 1999 Jan 20;281 (3): 249–54. doi:10.1001/jama.281.3.249.
   PubMed Web of Science ®Google Scholar
• Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5(1):30. doi:10.1186/1750-1172-5-30.
   PubMedGoogle Scholar
• Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004;34(3):236–42. doi:10.1111/j.1365-2362.2004.01309.x.
   PubMed Web of Science ®Google Scholar
• Schiffmann R, Kopp JB, Austin III HA, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. Jama. 2001;285(21):2743–49. doi:10.1001/jama.285.21.2743.
   PubMed Web of Science ®Google Scholar
• Franceschetti AT. Fabry disease: ocular manifestations. Birth Defects Orig Artic Ser. 1976;12(3):195–208.
   PubMedGoogle Scholar
• Samiy N. Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder. Surv Ophthalmol. 2008;53(4):416–23.
   PubMed Web of Science ®Google Scholar
• Sivley MD, Benjamin WJ. Fabry keratopathy: manifestations and changes over time. Br J Ophthalmol. 2020;104(8):1148–55.
   PubMed Web of Science ®Google Scholar
• Slowik C, Somodi S, von Gruben C, Richter A, Guthoff R. Erfassung morphologischer Hornhautveränderungen infolge Chloroquintherapie mit Hilfe der konfokalen In-vivo-Mikroskopie. Ophthalmologe. 1997;94(2):147–51. doi:10.1007/s003470050096.
   PubMedGoogle Scholar
• Wasielica-Poslednik J, Pfeiffer N, Reinke J, Pitz S. Confocal laser-scanning microscopy allows differentiation between Fabry disease and amiodarone-induced keratopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249(11):1689–96. doi:10.1007/s00417-011-1726-5.
   PubMed Web of Science ®Google Scholar
• Sher NA, Letson RD, Desnick RJ. The ocular manifestations in Fabry’s disease. Arch Ophthalmol. 1979;97(4):671–76.
   PubMedGoogle Scholar
• Spaeth GL, Frost P. Fabry’s disease. Its ocular manifestations. Arch Ophthalmol. 1965;74(6):760–69.
   PubMedGoogle Scholar
• Libert J, Toussaint D. Tortuosities of retinal and conjunctival vessels in lysosomal storage diseases. Birth Defects Orig Artic Ser. 1982;18(6):347–58.
   PubMedGoogle Scholar
• Font RL, Fine BS. Ocular pathology in Fabry’s disease. Histochemical and electron microscopic observations. Am J Ophthalmol. 1972;73(3):419–30.
   PubMed Web of Science ®Google Scholar
• Sher NA, Reiff W, Letson RD, Desnick RJ. Central retinal artery occlusion complicating Fabry’s disease. Arch Ophthalmol. 1978;96(5):815–17. doi:10.1001/archopht.1978.03910050421003.
   PubMedGoogle Scholar
• Andersen MV, Dahl H, Fledelius H, Nielsen NV. Central retinal artery occlusion in a patient with Fabry’s disease documented by scanning laser ophthalmoscopy. Acta Ophthalmol (Copenh). 1994;72(5):635–38. doi:10.1111/j.1755-3768.1994.tb07193.x.
   PubMed Web of Science ®Google Scholar
• Oto S, Kart H, Kadayifçilar S, Özdemir N, Aydin P. Retinal vein occlusion in a woman with heterozygous Fabry’s disease. Eur J Ophthalmol. 1998;8(4):265–67. doi:10.1177/112067219800800412.
   PubMed Web of Science ®Google Scholar
• Rahman AN. The ocular manifestations of hereditary dystopic lipidosis (angiokeratoma corporis diffusum universale). Arch Ophthalmol. 1963;69(6):708–16. doi:10.1001/archopht.1963.00960040714005.
   PubMedGoogle Scholar
• Edwards JD, Bower KS, Brooks DB. Fabry disease and chemosis. Cornea. 2009;28(2):224–27.
   PubMed Web of Science ®Google Scholar
• Klein P. Ocular manifestations of Fabry’s disease. J Am Optom Assoc. 1986;57(9):672–74.
   PubMedGoogle Scholar
• Velzeboer CM, de Groot WP. Ocular manifestations in angiokeratoma corporis diffusum (Fabry). Br J Ophthalmol. 1971;55(10):683–92.
   PubMed Web of Science ®Google Scholar
• Abe H, Sakai T, Sawaguchi S, Hasegawa S, Takagi M, Yoshizawa T, Usui T, Horikawa Y. Ischemic optic neuropathy in a female carrier with Fabry’s disease. Ophthalmologica. 1992;205(2):83–88. doi:10.1159/000310318.
   PubMed Web of Science ®Google Scholar
• Mignani R, Pieruzzi F, Berri F, Burlina A, Chinea B, Gallieni M, Pieroni M, Salviati A, Spada M. FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease. Clin Kidney J. 2016;9(5):739–47. doi:10.1093/ckj/sfw082.
   PubMed Web of Science ®Google Scholar
• Mignani R, Pieroni M, Pisani A, Spada M, Battaglia Y, Verrecchia E, Mangeri M, Feriozzi S, Tanini I, De Danieli G, et al. New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases. Clin Kidney J. 2019;12(1):65–70. doi:10.1093/ckj/sfy108.
   PubMed Web of Science ®Google Scholar
• Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050–58.
   PubMed Web of Science ®Google Scholar
• Pitz S, Kalkum G, Arash L, Karabul N, Sodi A, Larroque S, Beck M, Gal A. Ocular signs correlate well with disease severity and genotype in Fabry disease. PLoS One. 2015;10(3):e0120814. doi:10.1371/journal.pone.0120814.
   PubMed Web of Science ®Google Scholar
• Sodi A, Ioannidis AS, Mehta A, Davey C, Beck M, Pitz S. Ocular manifestations of Fabry’s disease: data from the Fabry outcome survey. Br J Ophthalmol. 2007;91(2):210–14. doi:10.1136/bjo.2006.100602.
   PubMed Web of Science ®Google Scholar
• Moiseev SV, Ismailova DS, Moiseev AS, Bulanov NM, Karovaikina EA, Nosova NR, Fomin VV. Cornea verticillata in Fabry disease. Ter Arkh. 2018;90(12):17–22. doi:10.26442/00403660.2018.12.000003.
   PubMed Web of Science ®Google Scholar
• Ries M, Gupta S, Moore DF, Sachdev V, Quirk JM, Murray GJ, Rosing DR, Robinson C, Schaefer E, Gal A, et al. Pediatric Fabry disease. Pediatrics. 2005;115(3):e344–55. doi:10.1542/peds.2004-1678.
   PubMed Web of Science ®Google Scholar
• Morier AM, Minteer J, Tyszko R, McCann R, Clarke MV, Browning MF. Ocular manifestations of Fabry disease within in a single kindred. Optometry. 2010;81(9):437–49. doi:10.1016/j.optm.2010.02.011.
   PubMedGoogle Scholar
• Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, Bultas J, Lee P, Sims K, Brodie SE, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006;8(9):539–48. doi:10.1097/01.gim.0000237866.70357.c6.
   PubMed Web of Science ®Google Scholar
• Cakmak AI, Atalay E, Cankurtaran V, Yaşar E, Turgut FH. Optical coherence tomography angiography analysis of Fabry disease. Int Ophthalmol. 2020;40(11):3023–32. doi:10.1007/s10792-020-01486-2.
   PubMed Web of Science ®Google Scholar